Bio-Speedy Sepsis qPCR MX-30 Panel
Sepsis causes prolonged hospitalizations and deaths. Appropriate treatment and rapid recovery process are possible with early diagnosis of sepsis agent. The chance of living with sepsis decreases suddenly as the treatment initiation is delayed. If a patient receives the correct antimicrobial treatment within the first hour of diagnosis, the chance of survival is close to 80%; this rate decreases by 7.6% for each delayed hour.
Intended use: Bio-Speedy® Sepsis qPCR MX-30 Panel is a multiplex kit designed to detect and differentiate 5 fungal, 17 bacterial, and 9 antimicrobial resistance gene agents.
.jpg)
